Detalles de la búsqueda
1.
Sweet Battle of the EpimersâContinued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy.
Mol Pharm
; 20(6): 3127-3139, 2023 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37134022
2.
Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity.
Mol Pharm
; 18(8): 3125-3131, 2021 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34296616
3.
Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates.
Mol Pharm
; 18(1): 285-304, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33390018
4.
Addressing the Biochemical Foundations of a Glucose-Based "Trojan Horse"-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment.
Mol Pharm
; 17(10): 3885-3899, 2020 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32787269
5.
Increasing the Potential of the Auristatin Cancer-Drug Family by Shifting the Conformational Equilibrium.
Mol Pharm
; 16(8): 3600-3608, 2019 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31199662
6.
Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter.
ACS Omega
; 7(34): 30376-30388, 2022 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36061667
Resultados
1 -
6
de 6
1
Próxima >
>>